6 -

6 - Lara PN, Jr., Chansky K, Davies AM et al. Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327). J Thorac Oncol 2006; 1(9):996-1001.